Holland & Knight’s Drug and Device Supply Chain practice continues to see increasing demand for deep experience in navigating the nuanced opportunities and challenges present in the delivery of drugs and devices to patients. Investment activity in this sector has seen a recent surge due to a confluence of factors, making it an attractive sector for investors seeking both financial returns and positive social impact. The sector comprises companies that directly deliver drugs and devices to patients (e.g., pharmacies, device suppliers and infusion service providers), companies further up the supply chain (e.g., distributors and wholesalers) and ancillary services providers (e.g., 340B consulting support, prior authorization platforms and specialty pharmacy management services).
Read the full article: Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors //
Source: https://www.hklaw.com/-/media/files/insights/publications/2026/01/hkhealthcaretrendreport_pharmacydrugsupplychain.pdf